/

Other

/

Stallergenes Greer

Stallergenes Greer

Stallergenes Greer

Verified Nov 2026

Other

·

Switzerland flag

Baar, Canton of Zug

·

Since 2015

Stallergenes Greer is a Swiss biopharmaceutical company headquartered in Baar, founded in 2015 through a merger combining over 120 years of expertise. With 1,000–5,000 employees and estimated revenue of $250–500M, it develops and manufactures allergen immunotherapy treatments across 46 countries. The company operates global manufacturing capacity for allergen and immunotherapy products, serving allergy specialists and healthcare professionals worldwide.

Stallergenes Greer

Verified Nov 2026

AT A GLANCE

Founded

2015

Headquarters

Switzerland flag

Baar, Canton of Zug

Employees

1,000-5,000

Ownership

Stallergenes Greer at a glance

Revenue

$250-500M

Est. band

Employees

1,000-5,000

Founded

2015

Headquarters

Baar, Canton of Zug

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Stallergenes Greer is a Swiss biopharmaceutical company headquartered in Baar, founded in 2015 through a merger combining over 120 years of expertise. With 1,000–5,000 employees and estimated revenue of $250–500M, it develops and manufactures allergen immunotherapy treatments across 46 countries. The company operates global manufacturing capacity for allergen and immunotherapy products, serving allergy specialists and healthcare professionals worldwide.

At a glance

Attribute

Detail

Founded

2015

Headquarters

Baar, Canton of Zug

Employees

1,000-5,000

Revenue

$250-500M (estimated)

What Stallergenes Greer makes

Stallergenes Greer offers subcutaneous injections, sublingual drops, sublingual tablets, and diagnostic components including enzyme-linked immunosorbent assay for severe allergic rhinitis and asthma.

Latest developments

Company details

The company operates significant production facilities in London, UK and North Carolina, USA, alongside its Swiss headquarters, and established market presence in China through a partnership agreement signed in 2025. Stallergenes Greer was founded in 2015, has an estimated 1,000-5,000 employees, and is headquartered in Baar, Canton of Zug.

Frequently asked questions

What does Stallergenes Greer do?

Stallergenes Greer is a Swiss biopharmaceutical company headquartered in Baar, founded in 2015 through a merger combining over 120 years of expertise. With 1,000–5,000 employees and estimated revenue of $250–500M, it develops and manufactures allergen immunotherapy treatments across 46 countries. The company operates global manufacturing capacity for allergen and immunotherapy products, serving allergy specialists and healthcare professionals worldwide.

Where is Stallergenes Greer headquartered?

Stallergenes Greer is headquartered in Baar, Canton of Zug (76b Zugerstrasse, Baar, Canton of Zug, 6340).

When was Stallergenes Greer founded?

Stallergenes Greer was founded in 2015.

How big is Stallergenes Greer?

Stallergenes Greer has an estimated 1,000-5,000 employees, with revenue in the $250-500M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Baar, Canton of Zug (HQ)Headquarters · Switzerland
Baar, Canton of Zug (HQ)76b Zugerstrasse, Baar, Canton of Zug, 6340, SwitzerlandHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.